Clariant AG (CLN) - Net Assets

Latest as of June 2025: CHF2.08 Billion CHF ≈ $2.63 Billion USD

Based on the latest financial reports, Clariant AG (CLN) has net assets worth CHF2.08 Billion CHF (≈ $2.63 Billion USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF5.82 Billion ≈ $7.35 Billion USD) and total liabilities (CHF3.74 Billion ≈ $4.72 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore CLN current and non-current assets for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric Value
Current Net Assets CHF2.08 Billion
% of Total Assets 35.75%
Annual Growth Rate 4.38%
5-Year Change 5.33%
10-Year Change 0.56%
Growth Volatility 24.67

Clariant AG - Net Assets Trend (2002–2024)

This chart illustrates how Clariant AG's net assets have evolved over time, based on quarterly financial data. For live valuation and market cap data, see market value of Clariant AG.

Annual Net Assets for Clariant AG (2002–2024)

The table below shows the annual net assets of Clariant AG from 2002 to 2024. Explore how efficiently does Clariant AG generate cash to assess how effectively this company generates cash.

Year Net Assets Change
2024-12-31 CHF2.51 Billion
≈ $3.17 Billion		 +15.05%
2023-12-31 CHF2.18 Billion
≈ $2.76 Billion		 -13.25%
2022-12-31 CHF2.51 Billion
≈ $3.18 Billion		 -1.22%
2021-12-31 CHF2.54 Billion
≈ $3.22 Billion		 +6.85%
2020-12-31 CHF2.38 Billion
≈ $3.01 Billion		 -11.06%
2019-12-31 CHF2.68 Billion
≈ $3.38 Billion		 -9.87%
2018-12-31 CHF2.97 Billion
≈ $3.75 Billion		 +1.05%
2017-12-31 CHF2.94 Billion
≈ $3.72 Billion		 +15.44%
2016-12-31 CHF2.55 Billion
≈ $3.22 Billion		 +2.09%
2015-12-31 CHF2.49 Billion
≈ $3.15 Billion		 -8.74%
2014-12-31 CHF2.73 Billion
≈ $3.46 Billion		 -1.69%
2013-12-31 CHF2.78 Billion
≈ $3.51 Billion		 -8.55%
2012-12-31 CHF3.04 Billion
≈ $3.84 Billion		 +0.46%
2011-12-31 CHF3.03 Billion
≈ $3.83 Billion		 +67.55%
2010-12-31 CHF1.81 Billion
≈ $2.28 Billion		 -4.75%
2009-12-31 CHF1.90 Billion
≈ $2.40 Billion		 -4.58%
2008-12-31 CHF1.99 Billion
≈ $2.51 Billion		 -16.23%
2007-12-31 CHF2.37 Billion
≈ $3.00 Billion		 -2.51%
2006-12-31 CHF2.43 Billion
≈ $3.08 Billion		 -6.10%
2005-12-31 CHF2.59 Billion
≈ $3.28 Billion		 +11.97%
2004-12-31 CHF2.31 Billion
≈ $2.93 Billion		 +86.61%
2003-12-31 CHF1.24 Billion
≈ $1.57 Billion		 +26.92%
2002-12-31 CHF977.00 Million
≈ $1.24 Billion		 --

Equity Component Analysis

This analysis shows how different components contribute to Clariant AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 303100000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CHF3.03 Billion 129.81%
Common Stock CHF584.00 Million 25.01%
Other Comprehensive Income CHF-1.53 Billion -65.65%
Other Components CHF253.00 Million 10.84%
Total Equity CHF2.33 Billion 100.00%

Clariant AG Competitors by Market Cap

The table below lists competitors of Clariant AG ranked by their market capitalization.

Company Market Cap
Also Holding AG
SW:ALSN
 $2.41 Billion
Zhejiang Huace Film TV Co
SHE:300133
 $2.41 Billion
Hyundai Elevator
KO:017800
 $2.41 Billion
Sinochem International Corp
SHG:600500
 $2.42 Billion
Vietnam Airlines JSC
VN:HVN
 $2.41 Billion
Sixt SE
XETRA:SIX2
 $2.41 Billion
Carmila SA
PA:CARM
 $2.41 Billion
CA Immobilien Anlagen AG
VI:CAI
 $2.41 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Clariant AG's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 2,018,000,000 to 2,335,000,000, a change of 317,000,000 (15.7%).
  • Net income of 244,000,000 contributed positively to equity growth.
  • Dividend payments of 139,000,000 reduced retained earnings.
  • Share repurchases of 14,000,000 reduced equity.
  • Other comprehensive income increased equity by 111,000,000.
  • Other factors increased equity by 115,000,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CHF244.00 Million +10.45%
Dividends Paid CHF139.00 Million -5.95%
Share Repurchases CHF14.00 Million -0.6%
Other Comprehensive Income CHF111.00 Million +4.75%
Other Changes CHF115.00 Million +4.93%
Total Change CHF- 15.71%

Book Value vs Market Value Analysis

This analysis compares Clariant AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.14x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 1.33x to 1.14x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-12-31 CHF6.06 CHF8.05 x
2003-12-31 CHF7.85 CHF8.05 x
2004-12-31 CHF10.65 CHF8.05 x
2005-12-31 CHF11.10 CHF8.05 x
2006-12-31 CHF10.46 CHF8.05 x
2007-12-31 CHF9.87 CHF8.05 x
2008-12-31 CHF8.51 CHF8.05 x
2009-12-31 CHF8.10 CHF8.05 x
2010-12-31 CHF6.74 CHF8.05 x
2011-12-31 CHF9.71 CHF8.05 x
2012-12-31 CHF9.24 CHF8.05 x
2013-12-31 CHF8.63 CHF8.05 x
2014-12-31 CHF8.10 CHF8.05 x
2015-12-31 CHF7.45 CHF8.05 x
2016-12-31 CHF7.56 CHF8.05 x
2017-12-31 CHF8.36 CHF8.05 x
2018-12-31 CHF8.47 CHF8.05 x
2019-12-31 CHF7.58 CHF8.05 x
2020-12-31 CHF6.77 CHF8.05 x
2021-12-31 CHF7.12 CHF8.05 x
2022-12-31 CHF7.08 CHF8.05 x
2023-12-31 CHF6.10 CHF8.05 x
2024-12-31 CHF7.07 CHF8.05 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Clariant AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 10.45%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 5.88%
  • • Asset Turnover: 0.66x
  • • Equity Multiplier: 2.68x
  • Recent ROE (10.45%) is above the historical average (2.02%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 -69.91% -6.85% 1.09x 9.35x CHF-730.40 Million
2003 14.71% 2.03% 1.06x 6.81x CHF55.40 Million
2004 6.73% 1.78% 1.05x 3.59x CHF-73.80 Million
2005 7.27% 2.38% 1.08x 2.84x CHF-69.10 Million
2006 -3.58% -1.05% 1.13x 3.03x CHF-322.30 Million
2007 0.22% 0.06% 1.17x 3.23x CHF-220.40 Million
2008 -1.91% -0.46% 1.36x 3.07x CHF-230.70 Million
2009 -11.17% -3.11% 1.09x 3.30x CHF-390.40 Million
2010 10.86% 2.68% 1.20x 3.37x CHF15.10 Million
2011 7.74% 3.08% 0.81x 3.10x CHF-66.30 Million
2012 7.35% 3.59% 0.63x 3.22x CHF-78.40 Million
2013 -0.74% -0.33% 0.74x 3.01x CHF-291.40 Million
2014 5.83% 2.49% 0.77x 3.03x CHF-108.90 Million
2015 9.47% 3.94% 0.78x 3.09x CHF-12.70 Million
2016 10.28% 4.33% 0.70x 3.40x CHF6.90 Million
2017 10.04% 4.34% 0.77x 2.98x CHF1.00 Million
2018 12.04% 5.09% 0.83x 2.85x CHF57.20 Million
2019 -1.36% -0.77% 0.55x 3.18x CHF-284.60 Million
2020 5.17% 3.01% 0.56x 3.09x CHF-108.20 Million
2021 14.59% 7.87% 0.62x 2.98x CHF108.20 Million
2022 -4.31% -1.94% 0.84x 2.64x CHF-335.10 Million
2023 6.64% 3.06% 0.82x 2.65x CHF-67.80 Million
2024 10.45% 5.88% 0.66x 2.68x CHF10.50 Million

Industry Comparison

This section compares Clariant AG's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $2,058,412,000
  • Average return on equity (ROE) among peers: 22.51%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Clariant AG (CLN) CHF2.08 Billion -69.91% 1.80x $2.41 Billion
EMS-CHEMIE HOLDING AG (EMSN) $1.11 Billion 20.90% 0.50x $14.92 Billion
Givaudan SA (GIVN) $4.57 Billion 23.45% 1.60x $25.74 Billion
Gurit Holding AG (GURN) $171.98 Million 27.28% 1.19x $119.06 Million
Sika AG (SIKA) $2.38 Billion 18.42% 1.02x $25.37 Billion

About Clariant AG

SW:CLN Switzerland Specialty Chemicals
Market Cap
$3.34 Billion
CHF2.64 Billion CHF
Market Cap Rank
#5578 Global
#79 in Switzerland
Share Price
CHF8.05
Change (1 day)
+0.81%
52-Week Range
CHF6.66 - CHF9.57
All Time High
CHF20.75
Categories
Companies in Switzerland Specialty Chemicals
About

Clariant AG develops, manufactures, distributes, and sells specialty chemicals in Switzerland, Europe, the Middle East, Africa, the United States, and the Asia Pacific. The Care Chemicals segment offers personal and home care, crop solutions, industrial applications, base chemicals, oil services, and mining solutions for various applications in home and personal care, coatings, adhesives, and agr… Read more